Riverside Capital has exchanged contracts to purchase a forward funding development in the heart of the “Cambridge Cluster”.

Plot 202 in Lancaster Way Business Park, just outside of Ely, will be developed to include a high-spec Research and Development facility and offices to meet the needs of Cambridge Nutritional Sciences Ltd (CNS).

The development has been pre-let to CNS on a 25 year lease with five yearly rent reviews linked to the Retail Price Index.

Interested in Riverside Capital’s investment opportunities? Register as a client, or contact us to find out more.